| Literature DB >> 22335899 |
Ismail Seckin1, Mumin Uzunalan, Meltem Pekpak, Sibel Kokturk, Huseyin Sonmez, Zeynep Oztürk, Sibel Demirci, Elif Yaprak.
Abstract
BACKGROUND: In experimentally induced puromycine aminonucleoside nephrosis (PAN) animal models, nephrotic syndrome with minimal change disease and focal and segmental sclerosis-like nephritis similar to that in human is demonstrated; however, the real mechanism of PAN is not yet elucidated. Platelet derived endothelial cell growth factor (PD-ECGF), an endothelial mitogen protein, is believed to take part in microvessel formation and in stimulation of angiogenesis and its expression has not been totally demonstrated in PAN rats yet. In this study, we aimed to examine PD-ECGF expression in acute and chronic PAN induced in rats and find out the association between its expression and the stages of angiogenesis in kidney.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22335899 PMCID: PMC3305375 DOI: 10.1186/1423-0127-19-24
Source DB: PubMed Journal: J Biomed Sci ISSN: 1021-7770 Impact factor: 8.410
Injection intervals and amounts of all groups
| Groups | Injection Intervals | Injection Amount | Total Injection Number | Sacrification day |
|---|---|---|---|---|
| Group I: Control | Daily | 1 ml isotonic NaCl | 9 | 10th day |
| Group II: Pre-proteinurea | Daily | 1.67 mg PA per 100 g body weight in 1 ml isotonic NaCl | 3 | 4th day |
| Group III: Acute Nephrosis | Daily | 1.67 mg PA per 100 g body weight in 1 ml isotonic NaCl | 9 | 10th day |
| Group IV: Chronic | Weekly in first 3 weeks Biweekly in the rest weeks | 1.67 mg PA per 100 g body weight in 1 ml isotonic NaCl | 7 | 12th week |
All groups: Proteinuria, Serum Albumin, Creatinine -Clearance, Weight
| Groups | Proteinuria mg/24 hours | Serum Albumin g/dl | Creatinin-Cl. ml/min | Weight g | |
|---|---|---|---|---|---|
| At start | 3.12 ± 2.40 | 105 ± 13.78 | |||
| Last | 4.87 ± 3 | 3.23 ± 0.10 | 0.55 ± 0.80 | 140 ± 15.49 | |
| At start > 3. inj. | 4.59 ± 3.70 | 100 ± 15.80 | |||
| 5.57 ± 2 | 3.02 ± 0.15 | 0.49 ± 0.80 | |||
| At start > 9.inj. | 5.04 ± 2 | 101 ± 0.80 | |||
| 91.34 ± 91* | 2.50 ± 0.63** | 0.38 ± 0.28** | |||
| At start > 7.inj. | 5.18 ± 2.20 | 100 ± 8.94 | |||
| 247.5 ± 90* | 2.35 ± 0.38** | 0.29 ± 0.10** | 210 ± 24.49** | ||
All data are presented as mean ± SD (median) and analyzed by Dunn Multiple Comparison Test following Kruskal Wallis ANOVA.
*p < 0.0025 **p < 0.05
For all groups their own control protein excretion (at start) is shown.
In all groups, number of cases and immunostaining for PD-ECGF
| Groups (n = 6) | Number of Cases | PD-ECGF |
|---|---|---|
| 6/6 | - | |
| 5/6 | + | |
| 4/6 | ++ | |
| 5/6 | ++++ | |
Immunpositivity is scored from 0 to 4 as (-none-, +1 weak immunpositivity, +2 moderate immunpositivity, + 3 strong immunpositivity, +4 very strong immunpositivity).
Total angiogenic stage counts in all groups
| Groups (n = 6) | Average angiogenic stage counts in 10 glomerules |
|---|---|
| 0.12 ± 0.04 | |
| 1.08 ± 0.03** | |
| 2.13 ± 0.14** | |
| 4.87 ± 0.21** | |
All data are presented as mean ± SD (median) and analyzed by Dunn Multiple Comparisons Test following One-way ANOVA.
**p < 0.01
Values of Proteinuria in acute nephrosis group/1-9. injections
| Rats | Proteinuria (mg/24 hours) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5.inj.a | ||||||||||
| 1st | 5.30 | 5.80 | 5.50 | 6.55 | 11.37 | 17.42 | 15.24 | 19.82 | 27.74 | 47.52 |
| 2nd | 3.39 | 4.62 | 6.43 | 8.22 | 11.32 | 14.35 | 18.52 | 17.68 | 24.22 | 41.55 |
| 3rd | 7.18 | 6.31 | 6.72 | 9.96 | 16.32 | 15.68 | 12.69 | 17.36 | 30.20 | 131.90 |
| 4th | 4.64 | 4.25 | 3.80 | 4.87 | 8.03 | 12.59 | 14.28 | 18.04 | 25.67 | 76.53 |
| 5th | 4.58 | 4.20 | 4.67 | 6.46 | 6.41 | 12.56 | 19.67 | 26.95 | 33.16 | 67.91 |
| 6th | 5.19 | 4.29 | 4.40 | 4.39 | 12.81 | 15.03 | 12.28 | 23.42 | 76.45 | 183.67 |
a. Proteinuria increased after the 5rd injection
Figure 1Expression of PDECGF in the control and experimental groups. Control group has no immunopositivity (A). Pre-proteinuria group has weak immunopositivity around the mesangial matrix (B). Acute group has moderate immunopositivity around the mesangial matrix regions (C). Chronic group has very strong immunopositivity in the cells of mesangial matrix regions (D). PDECGF- Negative chronic control group has no pozitivity (E) X40. Pozitive control is malignant melanoma tissue and has strong immunpozitivity in stromal cells (F) X20.
Figure 2(A) In an early stage of angiogenesis, an angiogenic cell island (circle) in the glomerulus without a basal lamina and lumen is seen in the semi-thin section of the acute group. X100. (B) In an early stage of angiogenesis, angiogenic cell islands (circles) in the expanded mesangial matrix of the glomeruli are seen in the semi thin section of the chronic group. X100. (C) In the early polarization stage of angiogenesis, two immature capillaries (circles) located inside an expanded dense mesangial matrix of a glomerulus are seen in the semi thin section of the chronic group. Endothelial cells have dense basophilic cytoplasms. X100. (D) In lumen formation stage of angiogenesis, an immature capillary (circle) in an expanded dense mesangial matrix with several vacuoles inside the dense basophilic endothelial cytoplasm is shown in the semi thin section of chronic group glomeruli. X100. (E) In the semi thin section of the chronic group's glomeruli, many macrophages (five ended stars), and immature capillaries (circles) in advanced stage of lumen (four ended stars) formation are seen. X100.
Figure 3(A) An electron micrograph from a glomerular area of the chronic group that shows an angiogenic cell island (circle) in enlarged mesangial matrix (MM) during early stage of angiogenesis. Lumen and basal lamina are not seen yet at the cell island. X2000. (B) Immature capillary (hearth-shaped) with a primitive lumen (star) and a macrophage (MA) in an increased mesangial matrix (MM) adherent to existing capillaries (CL), PAG: protein absorption granules in podocyte (PO), PL: Parietal layer. x2470. (C) A glomeruli area of the acute group that shows an immature capillary (circle) in primitive lumen formation stage. A primitive lumen formation (arrow) is observed in the cell island. The enlarged granular endoplasmic reticulum (GER) cisterns and well developed Golgi apparatus (GA) are seen in the endothelial cell's cytoplasm (shown with high magnification in the inset at the upper left x25000). Around immature capillary, a basal lamina can not be seen yet. N: Nucleus. X5000. (D) An area from a glomerulus of the chronic group that shows an immature capillary (circle) in subsequent stage of primitive lumen (stars) formation.x7500 In their cytoplasm, developed granular endoplasmic reticulum cisterns (GER) are seen in the inset at the upper left. X25000. (E) An area from a glomerulus of the acute group that shows an immature capillary (circle) containing an advanced stage of the lumen (stars) with an apoptotic endothelial cell and cell debris. In the periphery of the immature capillary, the basement membrane (arrows) becomes clear. PO: Podocyte, E: Apoptotic Endothelial cell nucleus, PAG: Protein Absorption Granule × 7500. (F) An area from a glomerulus of the chronic group that shows two small immature capillaries at the lumen formation stage (circle) and a foam-cell like macrophage (Ma) nearby. X5400.